Regina Brown - Jun 30, 2022 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Regina Brown
Stock symbol
LIXT
Transactions as of
Jun 30, 2022
Transactions value $
$0
Form type
4
Date filed
8/3/2022, 04:43 PM
Previous filing
Jul 2, 2021
Next filing
Nov 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIXT Options to Purchase Common Stock Award $0 +100K $0.00 100K Jun 30, 2022 Common 100K $0.74 Direct F1
holding LIXT Options to Purchase Common Stock 100K Jun 30, 2022 Common 100K $3.03 Direct
holding LIXT Options to Purchase Common Stock 250K Jun 30, 2022 Common 250K $2.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective June 30, 2022, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 30, 2022).